
1 

(1) This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1993, and shall come into force on 23rd August 1993.
(2) In this Order— “the principal Order” means the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983.
2 
In article 3(1)(a) of the principal Order (medicinal products on prescription only), for “Article 4(1), (1A), (1B), (1C), (1D) and (1E)”there is substituted “Article 4(1) to (1J)”.
3 
In article 4 of the principal Order (medicinal products that are not prescription only), the following paragraphs are inserted after paragraph (1E):“
(1F) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance acrivastine where—
(a) the medicinal product is sold or supplied in a container or package containing not more than 240 milligrams of acrivastine;
(b) its container or package is labelled to show a maximum daily dose of 24 milligrams of acrivastine.
(1G) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance cetirizine where—
(a) the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of cetirizine;
(b) its container or package is labelled to show a maximum daily dose of 10 milligrams of cetirizine.
(1H) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance ketoprofen where—
(a) the maximum strength of the ketoprofen in the medicinal product does not exceed two point five per cent.calculated in terms of weight in weight;
(b) the medicinal product is sold or supplied in a container or package containing not more than 30 grams of the medicinal product;
(c) the medicinal product is indicated only for treatment by external topical application, for rheumatic and muscular pain in adults and in children over the age of 12 years, for a maximum period of 7 days.
(1I) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance loratadine where—
(a) the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of loratadine;
(b) its container or package is labelled to show a maximum daily dose of 10 milligrams of loratadine.
(1J) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance terfenadine where—
(a) the medicinal product is sold or supplied in a container or package containing not more than 1200 milligrams of terfenadine;
(b) its container or package is labelled to show a maximum daily dose of 120 milligrams of terfenadine.”.
4 
In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed) the following substances are inserted at the appropriate points in the alphabetical order of the substances listed in column 1:
 Acemetacin
 Acitretin
 Aclarubicin Hydrochloride
 Acrivastine
 Adenosine
 Albendazole
 Aldesleukin
 Alfuzosin Hydrochloride
 Azithromycin
 Bambuterol Hydrochloride
 Cefixime
 Cefodizime Sodium
 Cefpodoxime Proxetil
 Celiprolol Hydrochloride
 Cetirizine
 Cilastatin Sodium
 Cilazapril
 Ciprofibrate
 Clarithromycin
 Colfosceril Palmitate
 Dalteparin Sodium
 Dexfenfluramine Hydrochloride
 Diclofenac Potassium
 Eflornithine Hydrochloride
 Enoxaparin Sodium
 Epirubicin Hydrochloride
 Epoetin Alfa
 Epoetin Beta
 Filgrastim
 Finasteride
 Flosequinan
 Fluticasone Propionate
 Formestane
 Fosfomycin
 Trometamol
 Fosinopril Sodium
 Gadoteridol
 Gestrinone
 Granisetron Hydrochloride
 Guanfacine Hydrochloride
 Halofantrine Hydrochloride
 Imipenem Hydrochloride
 Iomeprol
 Iopentol
 Iothalamic Acid
 Ioversol
 Ioxaglic Acid
 Ketorolac Trometamol
 Lacidipine
 Lamotrigine
 Lomefloxacin Hydrochloride
 Loratadine
 Mifepristone
 Mivacurium Chloride
 Moclobemide
 Molgramostim
 Mometasone Furoate
 Moracizine Hydrochloride
 Nafarelin Acetate
 Nitrendipine
 Norfloxacin
 Norgestimate
 Ofloxacin
 Ondansetron Hydrochloride
 Oxaprozin
 Oxitropium Bromide
 Oxybutynin Hydrochloride
 Paroxetine Hydrochloride
 Perfluamine
 Pergolide Mesylate
 Pravastatin Sodium
 Remoxipride Hydrochloride
 Risperidone
 Salmeterol Hydroxynaphthoate
 Sermorelin
 Sertraline Hydrochloride
 Sodium Clodronate
 Somatorelin Acetate
 Sultamicillin
 Sumatriptan Succinate
 Tazobactam Sodium
 Terfenadine
 Tibolone
 Tinzaparin
 Tolfenamic Acid
 Tropisetron Hydrochloride
 Tulobuterol
 Tulobuterol Hydrochloride
 Zuclopenthixol Acetate
5 
In Table A of Part IV of Schedule 1 to the principal Order (medicinal products specified by name and product licence number that are not prescription only medicines), immediately after the entry Zenoxone Ointment 0181/0032 there is inserted the following entry:“
 Zovirax Cold Sore Cream 0003/0304”.
Signed by authority of the Secretary of State for Health
Tom Sackville
Parliamentary Under Secretary of State,
Department of Health
19th July 1993John Redwood
Secretary of State for Wales
21st July 1993Fraser of Carmyllie
Minister of State Scottish Office
20th July 1993In witness whereof the Official Seal of the Minister of Agriculture, Fisheries and Food is hereto affixed on the
Gillian Shephard
Minister of Agriculture, Fisheries and Food
23rd July 1993.Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland this
J. Harbison
Under Secretary
19th day of July 1993.Sealed with the Official Seal of the Department of Agriculture for Northern Ireland this
W. J. Hodges
Permanent Secretary
19th day of July 1993.